BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17162661)

  • 1. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
    Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E
    J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
    Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
    Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis.
    Mozhgani SH; Jahantigh HR; Rafatpanah H; Valizadeh N; Mohammadi A; Basharkhah S; Rezaee SA
    Neurodegener Dis; 2018; 18(2-3):150-155. PubMed ID: 29990995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease.
    Yakova M; Lézin A; Dantin F; Lagathu G; Olindo S; Jean-Baptiste G; Arfi S; Césaire R
    Retrovirology; 2005 Feb; 2():4. PubMed ID: 15686595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.
    Mozhgani SH; Piran M; Zarei-Ghobadi M; Jafari M; Jazayeri SM; Mokhtari-Azad T; Teymoori-Rad M; Valizadeh N; Farajifard H; Mirzaie M; Khamseh A; Rafatpanah H; Rezaee SA; Norouzi M
    Retrovirology; 2019 Dec; 16(1):46. PubMed ID: 31888669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking.
    Sonoda J; Koriyama C; Yamamoto S; Kozako T; Li HC; Lema C; Yashiki S; Fujiyoshi T; Yoshinaga M; Nagata Y; Akiba S; Takezaki T; Yamada K; Sonoda S
    Cancer Sci; 2004 Jul; 95(7):596-601. PubMed ID: 15245597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.
    Boostani R; Khodabandeh M; Rezaee SA; Rafatpanah H; Ghezeldasht SA; Vahidi Z; Baghestani Z
    J Neurovirol; 2021 Dec; 27(6):831-837. PubMed ID: 33877590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.
    Morgan DJ; Caskey MF; Abbehusen C; Oliveira-Filho J; Araujo C; Porto AF; Santos SB; Orge GO; Joia MJ; Muniz AL; Siqueira I; Glesby MJ; Carvalho E
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1499-504. PubMed ID: 18160007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
    de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
    Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Profile of Blood Monocytes is Altered in HTLV-1 Infected Patients: Implications for HAM/TSP Disease.
    Echevarria-Lima J; de Abreu Pereira D; de Oliveira TS; de Melo Espíndola O; Lima MA; Celestino Leite AC; Sandim V; Rodrigues Nascimento C; E Kalume D; B Zingali R
    Sci Rep; 2018 Sep; 8(1):14354. PubMed ID: 30254298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy.
    Taylor GP; Hall SE; Navarrete S; Michie CA; Davis R; Witkover AD; Rossor M; Nowak MA; Rudge P; Matutes E; Bangham CR; Weber JN
    J Virol; 1999 Dec; 73(12):10289-95. PubMed ID: 10559346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations.
    Saab L; DiCapua D; Zubair AS
    J Neurol Sci; 2024 Apr; 459():122973. PubMed ID: 38520941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series.
    Meyerowitz EA; Mukerji SS; Kyle Harrold G; Erdil RM; Chen ST; Rudmann EA; Tsibris A; Venna N; Robbins GK
    Clin Infect Dis; 2023 Sep; 77(6):851-856. PubMed ID: 37157862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma.
    Yamada A; Yasunaga JI; Liang L; Zhang W; Sunagawa J; Nakaoka S; Iwami S; Kogure Y; Ito Y; Kataoka K; Nakagawa M; Iwanaga M; Utsunomiya A; Koh KR; Watanabe T; Nosaka K; Matsuoka M
    Cancer Sci; 2024 Jan; 115(1):310-320. PubMed ID: 37950425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM/TSP) treatment.
    Fadaee A; Mohammadi FS; Ariaee N; Ahmadi Ghezeldasht S; Valizadeh N; Kheradmand F; Boostani R; Rafatpanah H; Rezaee SA
    Mult Scler Relat Disord; 2024 Apr; 87():105659. PubMed ID: 38704874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
    Boostani R; Vakili R; Hosseiny SS; Shoeibi A; Fazeli B; Etemadi MM; Sabet F; Valizade N; Rezaee SA
    Neurotherapeutics; 2015 Oct; 12(4):887-95. PubMed ID: 26174324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-1 Proviral Load Absolute RT-qPCR Development for Assessing on Clinical Outcomes in HAM/TSP Patients.
    Ariaee N; Abbasnia S; Sabet F; Mirhossein A; Ahmadi Ghezeldasht S; Moshfegh M; Boostani R; Rezaee SA
    Rep Biochem Mol Biol; 2023 Oct; 12(3):393-402. PubMed ID: 38618262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Taylor GP; Weber JN; Bangham CR
    J Virol; 2003 Sep; 77(17):9716-22. PubMed ID: 12915584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Rafatpanah H; Farid Hosseini R; Pourseyed SH
    Iran J Basic Med Sci; 2013 Mar; 16(3):235-41. PubMed ID: 24470869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-1-associated myelopathy in Spain.
    de-Mendoza C; Pérez L; Rando A; Reina G; Aguilera A; Benito R; Eirós JM; Rodríguez-Avial I; Ortega D; Pozuelo MJ; Pena MJ; Soriano V;
    J Clin Virol; 2023 Dec; 169():105619. PubMed ID: 38000189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.